EWTX Stock Analysis: Buy, Sell, or Hold?
EWTX - Edgewise Therapeutics, Inc. Common Stock
$33.33
0.19 (0.57%)
▲
5d:
+5.31%
30d:
+15.41%
90d:
+34.31%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
EWTX is down 3.5% this week, but smart money is accumulating calls. Top strike: $33 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When EWTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EWTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EWTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EWTX is currently trading at $33.33, which is considered extended relative to its 30-day fair value range of $28.95 to $31.21.
Technical Outlook: Technically, EWTX is in a strong uptrend. The price is approaching resistance at $33.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EWTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $41.08 (+23.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EWTX is in a strong uptrend. The price is approaching resistance at $33.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EWTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $41.08 (+23.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$28.95 -
$31.21
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.8% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.3% below Wall St target ($41.08)
Fair Price Analysis
30-Day Fair Range
$28.95 -
$31.21
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$28.87
Resistance Level
$33.56
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.24
Wall Street Target
$41.08
(+23.3%)
Share & Embed Analysis
Last updated: April 05, 2026 4:51 PM ET
Data refreshes hourly during market hours. Next update: 5:51 PM
Data refreshes hourly during market hours. Next update: 5:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EWTX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Badreddin Edris
SELL
115471 shares
2026-01-21
Alan J Russell
SELL
100000 shares
2025-11-12
Jonathan C Fox
BUY
10700 shares
2025-11-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$138 | 61 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
